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Background
A problem for middle-income countries is unequal
access to medicines. In Republic of Moldova (RM),
reimbursed medicines did not decrease the burden of
expenditures for medicines. In this context, the aim of
this study was: evaluation of financial attractiveness for
community pharmacies to provide medicine reimburse-
ment services and factors that influence this process.
Methods
As methods of study we used a survey, direct observa-
tion, break-even analysis [1] and literature review. The
research was started in April 2014 and ended in May
2015. The study addressed revision of mark-up applied
by wholesale and retail companies for reimbursed medi-
cines, to improve availability and affordability for the
out-patient sector on reimbursed medicines [3] and to
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Figure 1 Relative frequency of cognitive implication
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Figure 2 Relative frequency of dispensing time
Figure 3 Financial analysis of pharmaceutical retail enterprises in RM, 2014
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analyze the capacity of pharmacists in providing cogni-
tive services for reimbursed medicines, with the future
possibility of pay for performance service implementa-
tion from the National Health Insurance Company
(NHIC)[2,4]. To assess the cognitive implication level
and the working time spent by pharmacists for dispen-
sing one reimbursed drug, one unreimbursed Rx drug
and one OTC drug, we asked pharmacists’ opinions
working in community pharmacies through a sociologi-
cal survey, in a sample of 300 people. Simultaneously,
time was assessed by direct observation in the phar-
macy. The financial analysis was made using data col-
lected from the National Bureau of Statistics and NHIC,
for 314 pharmacies in 2014.
Results
The cognitive implication for reimbursed drugs was
‘almost never’ or ‘permanently’, with a relative frequency
of 0.25 (Figure 1), and the most common time spent by
pharmacists for dispensing was 10 minutes, with a rela-
tive frequency of 0.18 (Figure 2). These results confirm
that the pharmacist loses most of their time for techni-
cal processing of the prescriptions, a fact demonstrated
through direct observation of the process. The median
of profitability for reimbursed drugs was -5.21%, for
unreimbursed drugs +2.16% (Figure 3). The break-even
point for reimbursed drugs is 22% of mark-up. The
results show that it is not convenient for pharmacies to
dispense medicines with reimbursed prescription
because of a lack of benefit for them.
Conclusions
It is recommended to review the added mark-ups for
reimbursed medicines in the retail pharmaceutical sector
from 15% to 22% (using regressive mark-ups); and to
introduce continuing education courses for pharmacists
in the field of adherence and compliance to treatment
for patients with non-communicable diseases, for medi-
cines from the reimbursement list.
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